Tanaka Kuniya, Shimada Hiroshi, Matsumoto Chizuru, Matsuo Kenichi, Nagano Yasuhiko, Endo Itaru, Togo Shinji
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Surgery. 2008 May;143(5):607-15. doi: 10.1016/j.surg.2008.01.006.
Although anatomic liver resection is preferred when treating hepatocellular carcinoma (HCC), evidence that it improves survival when compared with an adequate nonanatomic resection is lacking. The purpose of this study was to compare the survival impact of anatomic versus nonanatomic resection in patients with solitary HCC.
Clinicopathologic data were available for 125 patients who underwent hepatectomy for a solitary HCC confined to 1 or 2 Couinaud's segments. These patients were divided into 2 groups based on the hepatectomy procedure: anatomic (n = 83) and nonanatomic (n = 42) resection.
No differences were detected either in the hepatic recurrence rates (P = .38) or in the overall survival rates (P = .34) between the anatomic group and the nonanatomic group. The hepatectomy procedure (anatomic vs nonanatomic resection) did not affect survival in either univariate (P = 0.34) or multivariate analysis (relative risk, 1.574; P = .22). The proportion of patients who survived after recurrence was greater in the nonanatomic (15/42) than the anatomic group (13/83; P = .049), and the median survival time after recurrence was greater in patients who underwent nonanatomic resection (991 days; range, 131-4073 days) than in patients with anatomic resection (310 days; range, 48-1887 days; P = .045).
No superiority was seen in survival when HCC was treated by anatomic resection. Maintaining adequate liver function regardless of whether the resection is anatomic or not may be of greater importance.
尽管解剖性肝切除在治疗肝细胞癌(HCC)时是首选方法,但与充分的非解剖性切除相比,其能提高生存率的证据不足。本研究的目的是比较解剖性与非解剖性切除对孤立性HCC患者生存的影响。
125例因孤立性HCC行肝切除术且肿瘤局限于1或2个Couinaud肝段的患者的临床病理资料可用。根据肝切除手术方式将这些患者分为两组:解剖性切除组(n = 83)和非解剖性切除组(n = 42)。
解剖性切除组与非解剖性切除组之间在肝复发率(P = 0.38)或总生存率(P = 0.34)方面均未检测到差异。肝切除手术方式(解剖性与非解剖性切除)在单因素分析(P = 0.34)或多因素分析(相对风险,1.574;P = 0.22)中均不影响生存。复发后存活的患者比例在非解剖性切除组(15/42)高于解剖性切除组(13/83;P = 0.049),且非解剖性切除患者复发后的中位生存时间(991天;范围,131 - 4073天)长于解剖性切除患者(310天;范围,48 - 1887天;P = 0.045)。
解剖性切除治疗HCC在生存方面未见优势。无论切除是否为解剖性,维持足够的肝功能可能更为重要。